Skeletal Research Group, Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
PLoS One. 2018 Nov 15;13(11):e0207240. doi: 10.1371/journal.pone.0207240. eCollection 2018.
Irreversible cartilage collagen breakdown by the collagenolytic matrix metalloproteinases (MMPs)-1 and MMP-13 represents a key event in pathologies associated with tissue destruction such as arthritis. Inflammation is closely associated with such pathology and occurs in both rheumatoid and osteoarthritis making it highly relevant to the prevailing tissue damage that characterises these diseases. The inflammation-induced activating protein-1 (AP-1) transcription factor is an important regulator of both MMP1 and MMP13 genes with interplay between signalling pathways contributing to their expression. Here, we have examined the regulation of MMP1 expression, and using in vivo chromatin immunoprecipitation analyses we have demonstrated that cFos bound to the AP-1 cis element within the proximal MMP1 promoter only when the gene was transcriptionally silent as previously observed for MMP13. Subsequent small interfering RNA-mediated silencing confirmed however, that cFos significantly contributes to MMP1 expression. In contrast, silencing of ATF3 (a prime MMP13 modulator) did not affect MMP1 expression whilst silencing of the Wnt-associated regulator cysteine- serine-rich nuclear protein-1 (CSRNP1) resulted in substantial repression of MMP1 but not MMP13. Furthermore, following an early transient peak in expression of CSRNP1 at the mRNA and protein levels similar to that seen for cFOS, CSRNP1 expression subsequently persisted unlike cFOS. Finally, DNA binding assays indicated that the binding of CSRNP1 to the AP-1 consensus-like sequences within the proximal promoter regions of MMP1 and MMP13 was preferentially selective for MMP1 whilst activating transcription factor 3 (ATF3) binding was exclusive to MMP13. These data further extend our understanding of the previously reported differential regulation of these MMP genes, and strongly indicate that although cFos modulates the expression of MMP1/13, downstream factors such as CSRNP1 and ATF3 ultimately serve as transcriptional regulators in the context of an inflammatory stimulus for these potent collagenolytic MMPs.
胶原蛋白的破坏是由胶原酶基质金属蛋白酶(MMPs)-1 和 MMP-13 引起的,这是与组织破坏相关的病理学中的一个关键事件,如关节炎。炎症与这种病理学密切相关,发生在类风湿关节炎和骨关节炎中,因此与这些疾病的特征性组织损伤高度相关。炎症诱导的激活蛋白-1(AP-1)转录因子是 MMP1 和 MMP13 基因的重要调节因子,信号通路之间的相互作用有助于它们的表达。在这里,我们研究了 MMP1 表达的调节,并且使用体内染色质免疫沉淀分析,我们已经证明 cFos 仅在基因转录沉默时才与 MMP1 启动子近端的 AP-1 顺式元件结合,如先前观察到的 MMP13 一样。然而,随后的小干扰 RNA 介导的沉默证实 cFos 对 MMP1 表达有显著贡献。相比之下,沉默 ATF3(MMP13 的主要调节因子)不会影响 MMP1 表达,而沉默 Wnt 相关调节剂半胱氨酸-丝氨酸富含核蛋白-1(CSRNP1)会导致 MMP1 的显著抑制,但不会抑制 MMP13。此外,在 CSRNP1 的表达在 mRNA 和蛋白水平上出现类似于 cFOS 的早期短暂峰值之后,CSRNP1 的表达随后持续存在,而不像 cFOS 那样。最后,DNA 结合实验表明,CSRNP1 与 MMP1 和 MMP13 近端启动子区域内的 AP-1 类似序列的结合优先选择性地针对 MMP1,而激活转录因子 3(ATF3)的结合则是 MMP13 所特有的。这些数据进一步扩展了我们对这些 MMP 基因的差异调节的理解,并强烈表明,尽管 cFos 调节 MMP1/13 的表达,但 CSRNP1 和 ATF3 等下游因子最终作为这些强效胶原酶 MMP 的炎症刺激的转录调节剂。